Results 81 to 90 of about 1,923,361 (238)

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen   +7 more
wiley   +1 more source

3D Model of Fish (Cod. CL-001-078-3-543)

open access: yes, 2021
CÓDIGO DE LA PIEZA: CL-001-078-3-543 CATEGORÍA: Fósil CLASIFICACIÓN: Pez ADQUISICIÓN: Donación FECHA DE REGISTRO: 22-09-2022ITEM CODE: CL-001-078-3-543 CATEGORY: Fossil CLASSIFICATION: Fish ACQUISITION: Donation REGISTRATION DATE: 22-09 ...
Gómez Cruz, Arley de Jesús   +3 more
core  

Prevalence of pregnancy and birth outcomes following biologic exposure in immune‐mediated inflammatory diseases: A population‐based study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Almost 5% of pregnancies are affected by immune‐mediated inflammatory diseases (IMIDs). As treatments become available, understanding their use during pregnancy is important. We aimed to describe maternal, pregnancy and infant outcomes among IMID pregnancies exposed to biologic therapies. Methods Using the Merative™ MarketScan® Commercial Database,
Leah K. Flatman   +3 more
wiley   +1 more source

Commento artt. 543-554 c.p.c.

open access: yes, 2015
Commento artt.
laura durello
core  

Demographic characteristics of respondents (N = 543).

open access: yes, 2018
Demographic characteristics of respondents (N = 543).
Peter K. C. Lee (5580278)   +2 more
core   +1 more source

Analysis of regulatory review models and approval timelines across selected African medicines regulatory authorities using the OpERA framework (2020–2024)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background The World Health Organization (WHO) developed the Global Benchmarking Tool (GBT) to assess national regulatory systems and support regulatory‐system strengthening across regulatory functions. Several African National Medicines Regulatory Authorities (NMRAs) have achieved Maturity Level 3 (ML3).
Constance Sakala Chisha   +10 more
wiley   +1 more source

Commento art. 543-554 c.p.c.

open access: yes, 2018
COMMENTO ARTT.
Laura Durello, Andrea Graziosi
core  

The opportunity state and governing by benefits: Economic governmentality in Hong Kong's national education

open access: yesBritish Educational Research Journal, EarlyView.
Abstract National education in Hong Kong, understood here as a suite of state‐led curricular, co‐curricular and public‐pedagogy measures designed to cultivate national identity, constitutional loyalty and alignment with national development, has become a major focus of educational reform since 2020.
Jason Cong Lin
wiley   +1 more source

Relationship between the degree of Helicobacter pylori infection and miR-155 and miR-543 expression levels in gastric cancer

open access: yesBMC Gastroenterology
Background To analyze the relationship between Helicobacter pylori (HP) infection degree and miR-155 and miR-543 expression levels in gastric cancer (GC).
Ziwei Wang   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy